FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200473485> ?p ?o ?g. }

• W4200473485 abstract "BackgroundArginine vasopressin promotes kidney cyst growth in autosomal dominant polycystic kidney disease (ADPKD). Increased water intake reduces arginine vasopressin and urine osmolality and may slow kidney cyst growth.MethodsIn this randomized controlled 3-year clinical trial, we randomly assigned adults with ADPKD who had a height-corrected total kidney volume in Mayo imaging subclass categories 1B to 1E and an estimated glomerular filtration rate of 30 ml/min/1.73 m2 or greater to (1) water intake prescribed to reduce 24-hour urine osmolality to 270 mOsmol/kg or less or (2) ad libitum water intake irrespective of 24-hour urine osmolality. The primary end point was the percentage annualized rate of change in height-corrected total kidney volume.ResultsA total of 184 patients participated in either the ad libitum water intake group (n=92) or the prescribed water intake group (n=92). Over 3 years, there was no difference in the annualized rate of change in height-corrected total kidney volume between the ad libitum (7.8% per year; 95% confidence interval [CI], 6.6 to 9.0) and prescribed (6.8% per year; 95% CI, 5.8 to 7.7) water intake groups (mean difference, −0.97% per year; 95% CI, −2.37 to 0.44; P=0.18). The difference in mean 24-hour urine osmolality between the ad libitum and prescribed water intake groups was −91 mOsmol/kg (95% CI, −127 to −54 mOsmol/kg), with 52.3% of patients achieving adherence to the target 24-hour urine osmolality and no reduction in serum copeptin over 3 years. The frequency of adverse events was similar between groups.ConclusionsFor patients with ADPKD, prescribed water intake was not associated with excess adverse events and achieved the target 24-hour urine osmolality for half of the patients but did not reduce copeptin or slow the growth of total kidney volume over 3 years compared with ad libitum water intake. (Funded by the National Health and Medical Research Council of Australia [grant GNT1138533], Danone Research, PKD Australia, the University of Sydney, and the Westmead Medical Research Foundation; Australian New Zealand Clinical Trials Registry number, ACTRN12614001216606)." @default.
• W4200473485 created "2021-12-31" @default.
• W4200473485 creator A5001559641 @default.
• W4200473485 creator A5004097203 @default.
• W4200473485 creator A5005504016 @default.
• W4200473485 creator A5008832314 @default.
• W4200473485 creator A5012763174 @default.
• W4200473485 creator A5013402739 @default.
• W4200473485 creator A5015788445 @default.
• W4200473485 creator A5016336723 @default.
• W4200473485 creator A5017863972 @default.
• W4200473485 creator A5022521067 @default.
• W4200473485 creator A5032055037 @default.
• W4200473485 creator A5037431348 @default.
• W4200473485 creator A5038467679 @default.
• W4200473485 creator A5039458104 @default.
• W4200473485 creator A5040533032 @default.
• W4200473485 creator A5041130177 @default.
• W4200473485 creator A5041460197 @default.
• W4200473485 creator A5043721281 @default.
• W4200473485 creator A5044536911 @default.
• W4200473485 creator A5049307273 @default.
• W4200473485 creator A5054054990 @default.
• W4200473485 creator A5057610836 @default.
• W4200473485 creator A5059612135 @default.
• W4200473485 creator A5060578458 @default.
• W4200473485 creator A5063529423 @default.
• W4200473485 creator A5065648499 @default.
• W4200473485 creator A5067719448 @default.
• W4200473485 creator A5071405138 @default.
• W4200473485 creator A5071516231 @default.
• W4200473485 creator A5073057243 @default.
• W4200473485 creator A5074760833 @default.
• W4200473485 creator A5075474387 @default.
• W4200473485 creator A5077107645 @default.
• W4200473485 creator A5079226812 @default.
• W4200473485 creator A5083175659 @default.
• W4200473485 creator A5084102359 @default.
• W4200473485 creator A5087336965 @default.
• W4200473485 creator A5088285074 @default.
• W4200473485 date "2022-01-09" @default.
• W4200473485 modified "2023-09-29" @default.
• W4200473485 title "Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease" @default.
• W4200473485 cites W1941574658 @default.
• W4200473485 cites W2019019895 @default.
• W4200473485 cites W2064249981 @default.
• W4200473485 cites W2065603011 @default.
• W4200473485 cites W2097584753 @default.
• W4200473485 cites W2102861423 @default.
• W4200473485 cites W2112643254 @default.
• W4200473485 cites W2123000903 @default.
• W4200473485 cites W2125358538 @default.
• W4200473485 cites W2130729770 @default.
• W4200473485 cites W2134587505 @default.
• W4200473485 cites W2143085472 @default.
• W4200473485 cites W2143990369 @default.
• W4200473485 cites W2145403032 @default.
• W4200473485 cites W2152939922 @default.
• W4200473485 cites W2162966061 @default.
• W4200473485 cites W2207967588 @default.
• W4200473485 cites W2276596278 @default.
• W4200473485 cites W2279628312 @default.
• W4200473485 cites W2521524560 @default.
• W4200473485 cites W2522215880 @default.
• W4200473485 cites W2544019344 @default.
• W4200473485 cites W2589136630 @default.
• W4200473485 cites W2709557052 @default.
• W4200473485 cites W2765795120 @default.
• W4200473485 cites W2801895103 @default.
• W4200473485 cites W2808755720 @default.
• W4200473485 cites W2888346415 @default.
• W4200473485 cites W2903659263 @default.
• W4200473485 cites W2907006897 @default.
• W4200473485 cites W2922441540 @default.
• W4200473485 cites W2970412630 @default.
• W4200473485 cites W2982586187 @default.
• W4200473485 cites W3021964512 @default.
• W4200473485 cites W3035104393 @default.
• W4200473485 cites W3039485340 @default.
• W4200473485 doi "https://doi.org/10.1056/evidoa2100021" @default.
• W4200473485 hasPublicationYear "2022" @default.
• W4200473485 type Work @default.
• W4200473485 citedByCount "10" @default.
• W4200473485 countsByYear W42004734852022 @default.
• W4200473485 countsByYear W42004734852023 @default.
• W4200473485 crossrefType "journal-article" @default.
• W4200473485 hasAuthorship W4200473485A5001559641 @default.
• W4200473485 hasAuthorship W4200473485A5004097203 @default.
• W4200473485 hasAuthorship W4200473485A5005504016 @default.
• W4200473485 hasAuthorship W4200473485A5008832314 @default.
• W4200473485 hasAuthorship W4200473485A5012763174 @default.
• W4200473485 hasAuthorship W4200473485A5013402739 @default.
• W4200473485 hasAuthorship W4200473485A5015788445 @default.
• W4200473485 hasAuthorship W4200473485A5016336723 @default.
• W4200473485 hasAuthorship W4200473485A5017863972 @default.
• W4200473485 hasAuthorship W4200473485A5022521067 @default.
• W4200473485 hasAuthorship W4200473485A5032055037 @default.
• W4200473485 hasAuthorship W4200473485A5037431348 @default.
• W4200473485 hasAuthorship W4200473485A5038467679 @default.
• W4200473485 hasAuthorship W4200473485A5039458104 @default.

• next